🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of vaccine the...
Status
Completed
Location
Mayo Clinic
Start Date
2006-11-30
Trial ID
NCT00450814
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-05
Trial ID
NCT00085462
The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00157196
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Biomira Inc.
Start Date
1999-01
Trial ID
NCT00003638
Treatments Being Tested
Background: * Severe aplastic anemia (SAA) can lead to problems with bone ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-08
Trial ID
NCT01187017
Treatments Being Tested
This study is being conducted in order determine whether IMA910 as single a...
Status
Completed
Location
Medische Oncologie, Imeldaziekenhuis
Start Date
2008-06
Trial ID
NCT00785122
Treatments Being Tested
Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Status
Completed
Location
Scottsdale Healthcare Research Institute
Start Date
2014-02-05
Trial ID
NCT02004262
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184